103 related articles for article (PubMed ID: 1359101)
1. Anorectic activity of fluoxetine and norfluoxetine in mice, rats and guinea-pigs.
Anelli M; Bizzi A; Caccia S; Codegoni AM; Fracasso C; Garattini S
J Pharm Pharmacol; 1992 Aug; 44(8):696-8. PubMed ID: 1359101
[TBL] [Abstract][Full Text] [Related]
2. Anorectic activity of fluoxetine and norfluoxetine in rats: relationship between brain concentrations and in-vitro potencies on monoaminergic mechanisms.
Caccia S; Bizzi A; Coltro G; Fracasso C; Frittoli E; Mennini T; Garattini S
J Pharm Pharmacol; 1992 Mar; 44(3):250-4. PubMed ID: 1354734
[TBL] [Abstract][Full Text] [Related]
3. The effects of single and repeated anorectic doses of 5-hydroxytryptamine uptake inhibitors on indole levels in rat brain.
Caccia S; Anelli M; Codegoni AM; Fracasso C; Garattini S
Br J Pharmacol; 1993 Sep; 110(1):355-9. PubMed ID: 7693282
[TBL] [Abstract][Full Text] [Related]
4. Comparative studies on the anorectic activity of d-fenfluramine in mice, rats, and guinea pigs.
Mennini T; Bizzi A; Caccia S; Codegoni A; Fracasso C; Frittoli E; Guiso G; Padura IM; Taddei C; Uslenghi A
Naunyn Schmiedebergs Arch Pharmacol; 1991 May; 343(5):483-90. PubMed ID: 1881458
[TBL] [Abstract][Full Text] [Related]
5. Influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat.
Caccia S; Cappi M; Fracasso C; Garattini S
Psychopharmacology (Berl); 1990; 100(4):509-14. PubMed ID: 2320712
[TBL] [Abstract][Full Text] [Related]
6. Drug concentrations in mouse brain at pharmacologically active doses of fluoxetine enantiomers.
Fuller RW; Snoddy HD
Biochem Pharmacol; 1993 Jun; 45(11):2355-8. PubMed ID: 8517878
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of rat brain monoamine oxidase enzymes by fluoxetine and norfluoxetine.
Holt A; Baker GB
Naunyn Schmiedebergs Arch Pharmacol; 1996 Jun; 354(1):17-24. PubMed ID: 8832583
[TBL] [Abstract][Full Text] [Related]
8. Comparison of norfluoxetine enantiomers as serotonin uptake inhibitors in vivo.
Fuller RW; Snoddy HD; Krushinski JH; Robertson DW
Neuropharmacology; 1992 Oct; 31(10):997-1000. PubMed ID: 1279447
[TBL] [Abstract][Full Text] [Related]
9. Progress report on the anorectic effects of dexfenfluramine, fluoxetine and sertraline.
Garattini S; Bizzi A; Caccia S; Mennini T
Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 3():S43-50. PubMed ID: 1338321
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of norfluoxetine in rats: Increasing extracellular serotonin level in the frontal cortex.
Qu Y; Aluisio L; Lord B; Boggs J; Hoey K; Mazur C; Lovenberg T
Pharmacol Biochem Behav; 2009 May; 92(3):469-73. PubMed ID: 19463261
[TBL] [Abstract][Full Text] [Related]
11. Norfluoxetine enantiomers as inhibitors of serotonin uptake in rat brain.
Wong DT; Bymaster FP; Reid LR; Mayle DA; Krushinski JH; Robertson DW
Neuropsychopharmacology; 1993 Jun; 8(4):337-44. PubMed ID: 8512621
[TBL] [Abstract][Full Text] [Related]
12. Effects of fluoxetine and norfluoxetine on 5-hydroxytryptamine metabolism in blood platelets and brain after administration to rats.
Bourdeaux R; Desor D; Lehr PR; Younos C; Capolaghi B
J Pharm Pharmacol; 1998 Dec; 50(12):1387-92. PubMed ID: 10052854
[TBL] [Abstract][Full Text] [Related]
13. Unsuspected poor metabolizer phenotypes of fluoxetine in bioavailability/bioequivalence studies from an indian population perspective. Retrospective pharmacokinetic data evaluation.
Kandasamy M; Tripathy K; Ravi S; Kamath N; Pai B; Srinivas NR; Kristjansson F; Thangam S
Arzneimittelforschung; 2010; 60(1):12-21. PubMed ID: 20184222
[TBL] [Abstract][Full Text] [Related]
14. Role of norfluoxetine in the inhibition of desipramine metabolism and in the inhibition of serotonin uptake after fluoxetine administration to rats.
Fuller RW; Snoddy HD
Res Commun Chem Pathol Pharmacol; 1991 Jul; 73(1):31-40. PubMed ID: 1715593
[TBL] [Abstract][Full Text] [Related]
15. Postmortem serum and tissue redistribution of fluoxetine and norfluoxetine in dogs following oral administration of fluoxetine hydrochloride (Prozac).
Pohland RC; Bernhard NR
J Forensic Sci; 1997 Sep; 42(5):812-6. PubMed ID: 9304827
[TBL] [Abstract][Full Text] [Related]
16. Neuropharmacological effects of low and high doses of repeated oral dexfenfluramine in rats: a comparison with fluoxetine.
Caccia S; Confalonieri S; Bergami A; Fracasso C; Anelli M; Garattini S
Pharmacol Biochem Behav; 1997 Aug; 57(4):851-6. PubMed ID: 9259015
[TBL] [Abstract][Full Text] [Related]
17. An update on the pharmacology of serotoninergic appetite-suppressive drugs.
Garattini S
Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 4():S41-8. PubMed ID: 1338385
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of fluoxetine in rhesus macaques following multiple routes of administration.
Sawyer EK; Howell LL
Pharmacology; 2011; 88(1-2):44-9. PubMed ID: 21757974
[TBL] [Abstract][Full Text] [Related]
19. Changes in dopamine metabolism in rat forebrain regions after cessation of long-term fluoxetine treatment: relationship with brain concentrations of fluoxetine and norfluoxetine.
Gardier AM; Lepoul E; Trouvin JH; Chanut E; Dessalles MC; Jacquot C
Life Sci; 1994; 54(4):PL51-6. PubMed ID: 8289580
[TBL] [Abstract][Full Text] [Related]
20. Fluoxetine increases the anorectic and long-term dopamine-depleting effects of phentermine.
Callahan BT; Yuan J; Ricaurte GA
Synapse; 2000 Dec; 38(4):471-6. PubMed ID: 11044894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
